◎ An fara buga wannan labarin a cikin harshen Sinanci na gargajiya a cikin fitowa ta 96 na "Ganoderma” (Disamba 2022), kuma an fara buga shi cikin Sauƙaƙen Sinanci akan “ganodermanews.com” (Janairu 2023), kuma yanzu an sake buga shi a nan tare da izinin marubucin.

A cikin labarin "TsarinReishidon hana mura ─ Isasshen lafiyayyen qi a cikin jiki zai hana mamaye abubuwan da ke haifar da cuta” a cikin fitowar ta 46 ta “Ganoderma"A cikin 2009, na ambata cewa ka'idar maganin gargajiya na kasar Sin ta yi imanin cewa kiwon lafiya da cututtuka na cikin jihohi daban-daban na "rikici tsakanin qi lafiya da cututtuka".Daga cikin su, “qi lafiyayye” na nufin yadda jikin dan Adam ke da karfin jure cututtuka, kuma “pathogenic qi” gaba daya yana nufin kwayoyin cuta da kwayoyin cuta da ke mamaye jikin dan Adam ko ciwace-ciwacen da ke haifarwa a cikin jiki.

Wato mutum yana cikin koshin lafiya domin isassun lafiyayyen qi a cikin jiki yana hana kutsawa cikin abubuwan da ke haifar da cutar, wato jikin mutum yana da karfin jure cututtuka, wanda hakan baya nufin cewa babu wani qi. a cikin jiki amma yana nufin cewa pathogenic qi a cikin jiki ba zai iya rinjayar qi mai lafiya ba;mutum yana cikin wani yanayi na rashin lafiya saboda abubuwan da ke haifar da cututtuka suna mamaye jiki da rashin lafiya qi, wato rashin lafiyan qi yana raunana juriyar cututtukan jiki, kuma tarin abubuwan da ke haifar da cututtuka a cikin jiki yana haifar da cututtuka.Hanyar da ta dace na jiyya ita ce kawar da abubuwan da ke haifar da cututtuka.Duk da haka, har ya zuwa yanzu, magungunan yammacin duniya ko magungunan gargajiya na kasar Sin ba za su iya kawar da wasu cututtuka gaba daya ba.

Ashe ba haka lamarin yake ba a yau novel coronavirus kamuwa da cuta?Saboda rashin takamaiman magungunan kashe kwayoyin cuta, magungunan yammacin duniya ko magungunan gargajiya na kasar Sin ba za su iya kashe ƙwayoyin cuta sosai ba.Dalilin da ya sa masu kamuwa da cutar za su iya murmurewa shi ne dogara ga ƙarfafa rigakafi na jiki (lafiya qi) bisa tushen jiyya na bayyanar cututtuka (saukar da rashin jin daɗi) don kawar da kwayar cutar (watau pathogenic qi).

Tsarin garkuwar jiki mai ƙarfi yana sa ya yi wahala ƙwayoyin cuta su haifar da cuta. 

Labarin coronavirus (SARS-CoV-2) ya kamu da cutar kuma ya lalata duniya tsawon shekaru 3.Ya zuwa karshen shekarar 2022, sama da mutane miliyan 600 ne suka kamu da cutar kuma sama da mutane miliyan 6 ne suka mutu.A halin yanzu, bambance-bambancen Omicron na novel coronavirus har yanzu suna yaduwa sosai a duniya.Ko da yake an rage yawan kamuwa da cutar da kuma yawan mace-macen su, yana da saurin yaduwa kuma yawan kamuwa da cutar ya yi yawa.

Magungunan rigakafi na zamani ba za su iya kashe takamaiman ƙwayoyin cuta ba, amma suna iya hana yaduwar ƙwayoyin cuta kawai.Baya ga matakan kariya na yau da kullun kamar sanya abin rufe fuska, mai da hankali kan tsabtace hannu, kiyaye nisantar da jama'a, da guje wa taro, abu mafi mahimmanci ba komai bane face "ƙarfafa qi mai lafiya".

Immunity yana nufin iyawar tsarin garkuwar jiki don yin tsayayya da kawar da mamayewar ƙwayoyin cuta kamar ƙwayoyin cuta da ƙwayoyin cuta, cire tsufa, matattu ko ƙwayoyin cuta a cikin jiki da abubuwan da ke haifar da rashin lafiyan halayen, kula da kwanciyar hankali na yanayin ciki na jiki kiyaye lafiyar jiki.

Abubuwa da yawa kamar damuwa na tunani, damuwa, yawan aiki, rashin abinci mai gina jiki, matsalar barci, rashin motsa jiki, tsufa, cututtuka da kwayoyi na iya shafar garkuwar jiki kuma suna iya haifar da hypofunction na rigakafi ko rashin aiki na rigakafi.

A lokacin barkewar cutar, wasu mutanen da ke da kusanci da mutanen da suka kamu da cutar ta coronavirus ba su yi rashin lafiya ba kuma sun zama masu cutar asymptomatic;wasu mutane sun yi rashin lafiya amma suna da alamu masu laushi.

Dalilin da ya sa wadannan mutane ba su da asymptomatic ko kuma suna da ƙananan alamu shine cewa ƙarfin rigakafi na jiki (lafiya qi) yana kashe kwayar cutar (pathogenic qi).Lokacin da akwai isasshen qi mai lafiya a cikin jiki, abubuwan ƙwayoyin cuta ba su da wata hanya ta mamaye jiki.

Tsarin tsari na Reishi yana ƙarfafa lafiya qi da kawar da ƙwayoyin cuta

Reishiyana haɓaka rigakafi kuma yana hana ƙwayoyin cuta.

Reishiyana da tasiri na haɓaka rigakafi.Da farko dai, Reishi na iya haɓaka aikin da ba na musamman na rigakafi na jiki ba, gami da haɓaka maturation, bambance-bambance da aikin ƙwayoyin dendritic, haɓaka ayyukan kashe kashe macrophages mononuclear da ƙwayoyin kisa na halitta, kuma yana iya kawar da ƙwayoyin cuta kai tsaye.

Na biyu,Reishiyana haɓaka ayyukan rigakafi na humoral da rigakafi na salon salula kamar haɓaka haɓakar ƙwayoyin B, haɓaka samar da immunoglobulin (antibody) IgM da IgG, haɓaka haɓakar ƙwayoyin T, haɓaka ayyukan kashe ƙwayoyin cytotoxic T (CTL), da inganta samar da cytokines kamar interleukin-1 (IL-1), interleukin-2 (IL-2) da kuma interferon-gamma (IFN-gamma).

Nazarin ya nuna cewa Reishi na iya hana garkuwar garkuwar jikin ƙwayoyin tumor, amma ko yana da irin wannan tasiri a kan rigakafin ƙwayoyin cuta ya rage saura a yi nazari akai.Duk da haka, saboda hypofunction na rigakafi da ke haifar da dalilai daban-daban kamar damuwa na tunani, damuwa, yawan aiki, tsufa, cututtuka da kwayoyi,Reishian tabbatar da taimakawa wajen dawo da aikin rigakafi na yau da kullun.

Tasirin haɓaka rigakafi na Reishi yana ba da tushen ka'idar don rigakafin kamuwa da cutar coronavirus.

Reishiyana kwantar da ruhu, yana tsayayya da damuwa kuma yana haɓaka rigakafi.

A lokacin cutar ta COVID-19, wasu mutane sun fuskanci tsoro, tashin hankali, damuwa, matsalar barci, har ma da bacin rai saboda damuwar tunani da cutar COVID-19 ke haifarwa ko rigakafin annoba da matakan sarrafawa, waɗanda duk za su shafi rigakafi.

A cikin labarin "Gwajin Dabbobi da Gwajin Dan Adam naGanoderma LucidumAgainst-Stress-Induced Immune Action Suppression" a cikin fitowar ta 63 naGanodermaa cikin 2014, na yi magana game da gwaje-gwajen magunguna waɗandaGanoderma luciduminganta aikin rigakafi na berayen da ke haifar da damuwa.Wannan takarda ya nuna cewa damuwa ta jiki da ta hankali da aka samar ta hanyar horarwa mai tsanani zai iya hana aikin rigakafi na 'yan wasa, amma Ganoderma lucidum zai iya inganta aikin rigakafi.

Waɗannan illolin suna da alaƙa da haɓakar rigakafi da haɓakar ruhohi da fasali naReishi.A wata kalma, Reishi yana taimakawa wajen rage damuwa ta hankali ta hanyar tasirinsa kamar su kwantar da hankali, maganin damuwa, da damuwa.Don haka, ba shi da wahala a yi tunanin cewa tasirin kwantar da ruhi na Reishi zai iya rage damuwar tunani da cutar ta COVID-19 ta haifar da haɓaka rigakafi.

Ganoderma lucidumHakanan yana da tasirin anti-novel coronavirus.

Ganoderma lucidumsananne ne don kaddarorin antiviral.A lokacin annoba, mutane sun fi damuwa da koGanoderma lucidumyana da tasirin anti-novel coronavirus (SARS-Cov-2).

Binciken da masana daga Academia Sinica, Taiwan da aka buga a cikin "Tsarin Cibiyar Nazarin Kimiyya ta Kasa" A cikin 2021 ya tabbatar da hakan.Ganoderma lucidumpolysaccharide (RF3) yana da tabbataccen tasirin cutar coronavirus a cikin vivo da in vitro antiviral gwajin, kuma ba mai guba bane.

Nazarin ya nuna cewa RF3 (2 μg / ml) yana da tasirin antiviral mai mahimmanci akan SARS-Cov-2 da aka yi amfani da shi a cikin vitro, kuma har yanzu yana da ayyukan hanawa lokacin da aka diluted zuwa sau 1280, amma ba shi da guba ga mai watsa shiri Vero E6. Kwayoyin.Gudanar da baka naGanoderma lucidumpolysaccharide RF3 (a kashi na yau da kullun na 30 mg/kg) na iya rage yawan ƙwayar cuta (abun ciki) a cikin huhu na hamsters da ke kamuwa da cutar SARS-Cov-2, amma nauyin dabbobin gwaji ba ya raguwa, yana nuna cewaGanoderma lucidumpolysaccharide ba mai guba bane (kamar yadda aka nuna a hoton da ke ƙasa) [1].

Sakamakon anti-novel coronavirus na abin da aka ambata a samaGanoderma lucidumpolysaccharides a cikin vivo da in vitro suna ba da tushen ka'idar don "kawar da abubuwan cutarwa" don rigakafin cutar kamuwa da cutar coronavirus.

Sakamakon gwaji naGanoderma lucidumpolysaccharides akan novel coronavirus in vivo da in vitro

Ganoderma lucidumyana inganta tasirin rigakafin cutar.

Alurar rigakafin ƙwayoyin cuta shiri ne na autoimmune da aka yi ta hanyar wucin gadi, kunnawa ko canza kwayoyin cuta ko sassansu don hana kamuwa da cuta.

Alurar riga kafi yana riƙe da halayen ƙwayar cuta ko sassanta don ƙarfafa tsarin garkuwar jiki.Alurar riga kafi da ƙwayoyin cuta na iya horar da tsarin rigakafi don gane ƙwayoyin cuta da haifar da immunoglobulins (kamar IgG da IgA rigakafi) don kariya daga cututtukan ƙwayoyin cuta da ƙwayoyin cuta.Lokacin da ƙwayoyin cuta suka shiga jiki a nan gaba, alluran rigakafi na iya ganewa kuma su kashe ƙwayoyin cuta.Har ila yau, alluran rigakafi na iya ƙarfafa rigakafi na salula kuma su samar da daidaitaccen ƙwaƙwalwar ajiyar rigakafi.Lokacin da ƙwayoyin cuta suka shiga jiki a nan gaba, maganin rigakafi na iya ganowa da kawar da ƙwayoyin cuta da sauri.

Ana iya gani daga wannan cewa manufar rigakafin ita ce kuma don hana mamaye abubuwan da ke haifar da cutar ta hanyar isassun lafiya mai lafiya a cikin jiki don samun takamaiman rigakafi na rigakafi.Ganoderma lucidumpolysaccharide kadai na iya haɓaka ƙayyadaddun rigakafi na jiki da kuma takamaiman rigakafin barkwanci da garkuwar salula.Haɗin kaiGanoderma lucidumkuma maganin rigakafi (antigen) yana da aikin adjuvant, wanda zai iya haɓaka rigakafi na antigen da kuma inganta tasirin maganin rigakafi.

A cikin labarin "Adjuvant Properties naGanoderma lucidumpolysaccharides - haɓaka tasirin rigakafin ƙwayoyin cuta” a cikin fitowar ta 92 naGanodermaa 2021, na gabatar da dalla-dalla cewaGanoderma lucidumpolysaccharides cire da kuma tsarkake dagaGanoderma lucidumJikunan 'ya'yan itace na iya haɓaka tasirin maganin alurar riga kafi na circovirus, rigakafin cutar zazzabin alade da kajin cutar ƙwayar cuta ta Newcastle, inganta samar da takamaiman ƙwayoyin cuta da cytokines na rigakafi irin su interferon-γ, rage alamun bayyanar cututtukan da ke haifar da harin ƙwayar cuta akan dabbobin gwaji da rage mace-mace.Waɗannan karatun suna ba da tushe don bincike da aikace-aikacenGanoderma lucidumdon haɓaka tasirin novel rigakafin cutar coronavirus.

"Ganoderma lucidum+ rigakafi” na iya inganta kariya. 

Kwayar cutar Omicron tana da ƙananan ƙwayoyin cuta da ƙarancin adadin masu mutuwa, amma yana da saurin yaduwa.Bayan an ɗaga sabon tsarin rigakafin cutar coronavirus, iyalai da yawa ko raka'a sun gwada ingancin nucleic acid ko saurin gwajin antigen.

Sabili da haka, mafi mahimmancin ma'auni na rigakafi ga waɗanda ba su juyo ba shine "ƙarfafa lafiya qi da kawar da pathogen", wato don haɓaka rigakafi don tsayayya da kamuwa da cuta.Ganoderma lucidumyana ɗaya daga cikin manyan zaɓuɓɓuka don haɓaka rigakafi.Tare daGanodermakariya hade da allurar rigakafi, za ku iya samun damar tserewa.

A karshe, ina fata da gaskeGanoderma lucidumwanda ke ƙarfafa qi lafiya kuma yana kawar da ƙwayoyin cuta za a iya amfani da su don hanawa da sarrafa cutar, shawo kan ƙwayoyin cuta, da kuma kare dukkan halittu masu rai.

Magana: 1. Jia-Tsrong Jan, et al.Gano samfuran magunguna da magungunan ganye a matsayin masu hana kamuwa da cutar SARS-CoV-2.Proc Natl Acad Sci Amurka.2021;118 (5): e2021579118.doi: 10.1073/ pnas.2021579118.

TaƙaiceGabatarwar Farfesa Zhi-binLin

Ya sadaukar da kansa ga karatunGanodermakusan rabin karni kuma ya kasance majagaba a cikin nazarin Ganoderma a kasar Sin.

Ya yi nasara a matsayin mataimakin shugaban jami'ar kiwon lafiya ta Beijing, mataimakin shugaban makarantar koyar da ilmin likitanci na jami'ar likitanci ta Beijing, da darektan cibiyar koyar da ilmin likitanci da kuma darektan sashen kula da harhada magunguna na jami'ar kiwon lafiya ta Beijing.A halin yanzu farfesa ne a Sashen Nazarin Harhada Magunguna, Makarantar Magungunan Basic na Jami'ar Kiwon Lafiya ta Beijing.

Daga 1983 zuwa 1984, ya kasance malami mai ziyara a Cibiyar Nazarin Magungunan Gargajiya ta WHO a Jami'ar Illinois da ke Chicago, Amurka, kuma malami ne mai ziyara a Jami'ar Hong Kong daga 2000 zuwa 2002. Tun daga 2006, ya kasance mai girmamawa. Farfesa a Kwalejin Magungunan Magunguna ta Jihar Perm a Rasha.

Tun daga 1970, ya yi amfani da hanyoyin fasaha na zamani don nazarin tasirin magunguna da hanyoyinGanodermada kayan aikin sa kuma ya buga fiye da 100 takardun bincike akan Ganoderma.

A cikin 2014 da 2019, an saka shi cikin jerin masu bincike na kasar Sin da aka fi sani da Elsevier ya buga tsawon shekaru shida a jere.

Shi ne marubucin adadinGanodermayana aiki kamar "Bincike na Zamani akan Ganoderma" (1-4 bugu), "Lingzhi Daga Mystery zuwa Kimiyya" (1-3 bugu), "Maganin Ciwon Ciwon Ciki tare da Lingzhi wanda ke ƙarfafa qi lafiya kuma yana kawar da ƙwayoyin cuta", "Magana game da Ganoderma". " da "Ganoderma da Lafiya".